ADASTRA PHARMACEUTICALS, INC.

Profile

Company Names

ADASTRA PHARMACEUTICALS, INC.
TRAGARA PHARMACEUTICALS, INC.
TRAGARA PHARMACEUTICALS INC

Addresses

12481 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO, CA 92130

3152 LIONSHEAD AVENUE, CARLSBAD, CA 92010

10955 VISTA SORRENTO PARKWAY, SUITE 120, SAN DIEGO, CA 92130

Phone Numbers

(949) 422-9676
(760) 208-6900
(858) 350-6900

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$28,771,559.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2019-04-12 
$2,250,223.00 
$12,001,200.00 
$9,750,977.00 
Equity 
5
2016-11-09 
$3,261,352.00 
$5,435,587.00 
$2,174,235.00 
Equity 
4
2015-08-28 
$13,058,784.00 
$13,058,784.00 
$0.00 
Equity 
3
2015-07-15 
$1,201,200.00 
$1,201,200.00 
$0.00 
Debt 
2
2012-07-26 
$4,000,000.00 
$6,000,000.00 
$2,000,000.00 
Debt 
1
2010-01-28 
$5,000,000.00 
$10,000,000.00 
$5,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DENNIS 
 
BILSKI 
EXECUTIVE OFFICER
GRIGORY 
 
BORISENKO 
DIRECTOR
CHRIS 
E. 
CHRISTOFFERSEN 
DIRECTOR
RALPH 
E. 
CHRISTOFFERSEN, PH.D. 
DIRECTOR
THOMAS 
ESTOK 
EXECUTIVE OFFICER, DIRECTOR
KIM 
P. 
KAMDAR 
DIRECTOR
KIM 
P. 
KAMDAR, PH.D. 
DIRECTOR
TRACY 
 
LAWHON 
EXECUTIVE OFFICER
CHRIS 
 
LEMASTERS 
EXECUTIVE OFFICER
SCOTT 
 
MEGAFFIN 
EXECUTIVE OFFICER, DIRECTOR
TRACY 
 
PARROTT 
EXECUTIVE OFFICER
ALAIN 
B. 
SCHREIBER, M.D. 
DIRECTOR
EVGENY 
 
ZAYTSEV, M.D. 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-12 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-28 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-07-15 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#